In the BELLWAVE-001 study of 112 patients with heavily pretreated hematological malignancies, 57 had CLL/SLL and among those 63% with C481S mutation 32% harbored a p53 mutation and 58% had IGHV-unmutated disease. Here, TP53 is linked to hematologic disorder.